questionsmedicales.fr
Glucides
Désoses
Désoses : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Carence en glucides
Tests biochimiques
Chromatographie
Analyse enzymatique
Fatigue
Troubles métaboliques
Tests génétiques
Anomalies métaboliques
Symptômes
5
Fatigue
Troubles de la croissance
Système immunitaire
Infections
Troubles neurologiques
Maux de tête
Troubles digestifs
Ballonnements
Énergie corporelle
Fatigue
Prévention
5
Prévention
Alimentation équilibrée
Groupes à risque
Troubles métaboliques
Surveillance
Analyses sanguines
Traitements
5
Suppléments
Modifications alimentaires
Phytothérapie
Thérapies alternatives
Administration intraveineuse
Désoses
Complications
5
Complications
Troubles métaboliques
Retard de croissance
Enfants
Maladies chroniques
Carences prolongées
Complications neurologiques
Fonction cognitive
Facteurs de risque
5
Facteurs de risque
Troubles digestifs
Personnes âgées
Besoins nutritionnels
Sportifs
Apports nutritionnels
Maladies génétiques
Métabolisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Désoses : Questions médicales les plus fréquentes",
"headline": "Désoses : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Désoses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Désoses"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glucides",
"url": "https://questionsmedicales.fr/mesh/D002241",
"about": {
"@type": "MedicalCondition",
"name": "Glucides",
"code": {
"@type": "MedicalCode",
"code": "D002241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désoxyglucose",
"alternateName": "Deoxyglucose",
"url": "https://questionsmedicales.fr/mesh/D003847",
"about": {
"@type": "MedicalCondition",
"name": "Désoxyglucose",
"code": {
"@type": "MedicalCode",
"code": "D003847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.254.229"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fluorodésoxyglucose F18",
"alternateName": "Fluorodeoxyglucose F18",
"url": "https://questionsmedicales.fr/mesh/D019788",
"about": {
"@type": "MedicalCondition",
"name": "Fluorodésoxyglucose F18",
"code": {
"@type": "MedicalCode",
"code": "D019788",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.254.229.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Désoxyribose",
"alternateName": "Deoxyribose",
"url": "https://questionsmedicales.fr/mesh/D003855",
"about": {
"@type": "MedicalCondition",
"name": "Désoxyribose",
"code": {
"@type": "MedicalCode",
"code": "D003855",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.254.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fucose",
"alternateName": "Fucose",
"url": "https://questionsmedicales.fr/mesh/D005643",
"about": {
"@type": "MedicalCondition",
"name": "Fucose",
"code": {
"@type": "MedicalCode",
"code": "D005643",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.254.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rhamnose",
"alternateName": "Rhamnose",
"url": "https://questionsmedicales.fr/mesh/D012210",
"about": {
"@type": "MedicalCondition",
"name": "Rhamnose",
"code": {
"@type": "MedicalCode",
"code": "D012210",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.254.799"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Désoses",
"alternateName": "Deoxy Sugars",
"code": {
"@type": "MedicalCode",
"code": "D003837",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hye-Kyung Na",
"url": "https://questionsmedicales.fr/author/Hye-Kyung%20Na",
"affiliation": {
"@type": "Organization",
"name": "Department of Food Science and Biotechnology, College of Knowledge Based Services Engineering, Sungshin Women's University, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Young-Joon Surh",
"url": "https://questionsmedicales.fr/author/Young-Joon%20Surh",
"affiliation": {
"@type": "Organization",
"name": "Tumor Microenvironment Global Core Research Center and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Yasuhiro Yamamoto",
"url": "https://questionsmedicales.fr/author/Yasuhiro%20Yamamoto",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Pharmaceutical Sciences, Himeji Dokkyo University."
}
},
{
"@type": "Person",
"name": "Hiromi Koma",
"url": "https://questionsmedicales.fr/author/Hiromi%20Koma",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Pharmaceutical Sciences, Himeji Dokkyo University."
}
},
{
"@type": "Person",
"name": "Tatsurou Yagami",
"url": "https://questionsmedicales.fr/author/Tatsurou%20Yagami",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Pharmaceutical Sciences, Himeji Dokkyo University."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum?",
"datePublished": "2024-10-24",
"url": "https://questionsmedicales.fr/article/39448656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-73619-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatment-planning approaches to intensity modulated proton therapy and the impact on dose-weighted linear energy transfer.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36161765",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.13782"
}
},
{
"@type": "ScholarlyArticle",
"name": "Calculating dose-averaged linear energy transfer in an analytical treatment planning system for carbon-ion radiotherapy.",
"datePublished": "2022-12-17",
"url": "https://questionsmedicales.fr/article/36527366",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.13866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Radio-fluorogenic nanoclay gel dosimeters with reduced linear energy transfer dependence for carbon-ion beam radiotherapy.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36335533",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mp.16092"
}
},
{
"@type": "ScholarlyArticle",
"name": "Linear energy transfer (LET) distribution outside small radiotherapy field edges produced by 6 MV X-rays.",
"datePublished": "2023-12-06",
"url": "https://questionsmedicales.fr/article/38052891",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-44409-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Désoses",
"item": "https://questionsmedicales.fr/mesh/D003837"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Désoses - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Désoses",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Désoses",
"description": "Comment diagnostiquer une carence en désoses ?\nQuels tests sont utilisés pour détecter les désoses ?\nLes désoses peuvent-ils être détectés dans l'urine ?\nQuels symptômes indiquent un problème avec les désoses ?\nLes tests génétiques sont-ils utiles pour les désoses ?",
"url": "https://questionsmedicales.fr/mesh/D003837?mesh_terms=Linear+Energy+Transfer#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Désoses",
"description": "Quels sont les symptômes d'une carence en désoses ?\nLes désoses affectent-ils le système immunitaire ?\nY a-t-il des symptômes neurologiques associés ?\nLes désoses peuvent-ils causer des problèmes digestifs ?\nComment les désoses influencent-ils l'énergie corporelle ?",
"url": "https://questionsmedicales.fr/mesh/D003837?mesh_terms=Linear+Energy+Transfer#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Désoses",
"description": "Comment prévenir les carences en désoses ?\nLes suppléments sont-ils nécessaires pour prévenir les carences ?\nY a-t-il des groupes à risque pour les carences en désoses ?\nLes enfants ont-ils besoin de plus de désoses ?\nComment surveiller les niveaux de désoses ?",
"url": "https://questionsmedicales.fr/mesh/D003837?mesh_terms=Linear+Energy+Transfer#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Désoses",
"description": "Quel traitement existe pour les carences en désoses ?\nLes médicaments peuvent-ils aider avec les désoses ?\nY a-t-il des thérapies alternatives pour les désoses ?\nComment l'alimentation influence-t-elle les désoses ?\nLes désoses peuvent-ils être administrés par voie intraveineuse ?",
"url": "https://questionsmedicales.fr/mesh/D003837?mesh_terms=Linear+Energy+Transfer#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Désoses",
"description": "Quelles complications peuvent survenir avec une carence en désoses ?\nLes désoses peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies chroniques ?\nLes complications neurologiques sont-elles possibles ?\nComment les désoses influencent-ils le métabolisme ?",
"url": "https://questionsmedicales.fr/mesh/D003837?mesh_terms=Linear+Energy+Transfer#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Désoses",
"description": "Quels sont les facteurs de risque pour les carences en désoses ?\nLes personnes âgées sont-elles à risque ?\nLes sportifs ont-ils besoin de plus de désoses ?\nLes maladies génétiques augmentent-elles le risque ?\nLe stress peut-il influencer les niveaux de désoses ?",
"url": "https://questionsmedicales.fr/mesh/D003837?mesh_terms=Linear+Energy+Transfer#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en désoses ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins et des analyses biochimiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les désoses ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de chromatographie et des analyses enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les désoses peuvent-ils être détectés dans l'urine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains désoses peuvent être identifiés dans les échantillons d'urine."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les désoses ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, des troubles métaboliques peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les désoses ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent aider à identifier des anomalies métaboliques liées aux désoses."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en désoses ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles de la croissance."
}
},
{
"@type": "Question",
"name": "Les désoses affectent-ils le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut affaiblir le système immunitaire, augmentant les infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques comme des maux de tête peuvent survenir en cas de carence."
}
},
{
"@type": "Question",
"name": "Les désoses peuvent-ils causer des problèmes digestifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent entraîner des troubles digestifs comme des ballonnements."
}
},
{
"@type": "Question",
"name": "Comment les désoses influencent-ils l'énergie corporelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence en désoses peut réduire la production d'énergie, entraînant fatigue."
}
},
{
"@type": "Question",
"name": "Comment prévenir les carences en désoses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en glucides complexes aide à prévenir les carences."
}
},
{
"@type": "Question",
"name": "Les suppléments sont-ils nécessaires pour prévenir les carences ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments peuvent être recommandés si l'alimentation est insuffisante en désoses."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque pour les carences en désoses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes avec des troubles métaboliques ou alimentaires sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les enfants ont-ils besoin de plus de désoses ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants en croissance ont besoin de niveaux adéquats de désoses pour leur développement."
}
},
{
"@type": "Question",
"name": "Comment surveiller les niveaux de désoses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans de santé réguliers et des analyses sanguines peuvent aider à surveiller les niveaux."
}
},
{
"@type": "Question",
"name": "Quel traitement existe pour les carences en désoses ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de désoses et des modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider avec les désoses ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent améliorer l'absorption des désoses dans l'organisme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives pour les désoses ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies comme la phytothérapie peuvent être envisagées, mais avec prudence."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle les désoses ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en glucides peut aider à maintenir des niveaux adéquats de désoses."
}
},
{
"@type": "Question",
"name": "Les désoses peuvent-ils être administrés par voie intraveineuse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas graves, les désoses peuvent être administrés par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en désoses ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques graves et des infections fréquentes."
}
},
{
"@type": "Question",
"name": "Les désoses peuvent-ils affecter la croissance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut entraîner un retard de croissance chez les enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence prolongée en désoses peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques peuvent survenir, affectant la fonction cognitive."
}
},
{
"@type": "Question",
"name": "Comment les désoses influencent-ils le métabolisme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence en désoses peut perturber le métabolisme énergétique et glucidique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les carences en désoses ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent une alimentation déséquilibrée, des troubles digestifs et métaboliques."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir des besoins nutritionnels spécifiques, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les sportifs ont-ils besoin de plus de désoses ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les sportifs peuvent nécessiter des apports plus élevés en désoses pour l'énergie."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent affecter le métabolisme des désoses, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer les niveaux de désoses ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber le métabolisme et affecter les niveaux de désoses."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/03/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
Department of Food Science and Biotechnology, College of Knowledge Based Services Engineering, Sungshin Women's University, Seoul, Korea.
6 publications dans cette catégorie
Affiliations :
Tumor Microenvironment Global Core Research Center and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.
Cancer Research Institute, Seoul National University, Seoul, South Korea.
2 publications dans cette catégorie
Affiliations :
Faculty of Pharmaceutical Sciences, Himeji Dokkyo University.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Faculty of Pharmaceutical Sciences, Himeji Dokkyo University.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Faculty of Pharmaceutical Sciences, Himeji Dokkyo University.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Korea.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
b Tumor Microenvironment Global Core Research Center, College of Pharmacy , Seoul National University , Seoul , South Korea.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, College of Korean Medicine, Daejeon University, Daejeon, Korea.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Department of Bioengineering, Faculty of Engineering, Izmir Institute of Technology, İzmir, Turkey.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan. umeda@u-fukui.ac.jp.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
2 publications dans cette catégorie
Affiliations :
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
Publications dans "Désoses" :
1 publication dans cette catégorie
Affiliations :
CIHIDECAR, Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón II, Ciudad Universitaria, 1428 Buenos Aires, Argentina. cmarino@qo.fcen.uba.ar.
Publications dans "Désoses" :
The choice of appropriate physical quantities to characterize the biological effects of ionizing radiation has evolved over time coupled with advances in scientific understanding. The basic hypothesis...
We quantified the effect of various forward-based treatment-planning strategies in proton therapy on dose-weighted linear energy transfer (LETd). By maintaining the dosimetric quality at a clinically ...
Eight treatment-planning strategies that are achievable in commercial treatment-planning systems were applied on a cylindrical water phantom and four pediatric brain tumor cases. Each planning strateg...
In the phantom study, using a range shifter and altering the robust scenarios during optimization had the largest effect on the mean clinical target volume LETd, which was reduced from 4.5 to 3.9 keV/...
Changes in LETd from treatment-plan setup follow intuitive trends in a controlled phantom experiment. Anatomical and other patient-specific considerations, however, can preclude generalizable strategi...
Compelling evidence shows the association between the relative biological effectiveness (RBE) of carbon-ion radiotherapy (CIRT) and the dose averaged linear energy transfer (LETd). However, the abilit...
This study aims to develop a method of calculating the LETd of CIRT plans that could be robustly carried out in RayStation (V10B, Raysearch, Sweden)....
The calculation used the fragment spectra in RayStation for the CIRT treatment planning. The dose-weighted averaging procedure was supported by the microdosimetric kinetic model (MKM). The MKM-based p...
The differences in LETds of the monoenergetic beams between the new method and the traditional method were within 3% in the entrance and Bragg-peak regions. However, a larger difference was observed i...
The method presented herein reformulates the MKM dose engine in the RayStation TPS to inversely calculate LETds. The robustness and accuracy were demonstrated....
The precise assessment of the dose distribution of high linear energy transfer (LET) radiation remains a challenge, because the signal of most dosimeters will be saturated due to the high ionization d...
Nanoclay radio-fluorogenic gel (NC-RFG) dosimeters were prepared, typically containing 100 μM dihydrorhodamine 123 (DHR123) and 2.0 wt% nanoclay together with catalytic additives promoting Fenton or F...
An NC-RFG dosimeter capable of generating a fluorescence intensity distribution reflecting the carbon-ion beam dose profile was obtained. It was clarified that the reduction of the unfavorable LET dep...
This technique allows the first-ever evaluation of the depth-dose profile of a carbon-ion beam at typical therapeutic levels of several Gy without LET effect....
In modern radiotherapy with photons, the absorbed dose outside the radiation field is generally investigated. But it is well known that the biological damage depends not only on the absorbed dose but ...
The use of radiation with low and high linear energy transfer (LET) in the same treatment regimen is promising in terms of increasing the efficiency and reducing the severity of radiation complication...
Different alpha exposure setups are often used to study the relation between biological responses and LET. This study aimed to estimate the dose heterogeneity and uncertainty in four exposure setups u...
Geant4 was used to estimate the dose distributions in cells grown on a disk exposed to alpha particles penetrating from above and below. The latter setup was simulated without and with a collimator. P...
The LET distributions obtained for simulated setups excluding the collimator were wide and non-Gaussian. Using a collimator resulted in a Gaussian LET distribution, but strongly reduced dose rate and ...
The interpretation of results from radiobiological experiments with alpha particles should always cover the characteristics of the experimental setup, which can be done precisely with computational me...
The correlation between dose-averaged linear energy transfer (LETd) and its therapeutic or adverse effects, especially in carbon-ion radiotherapy (CIRT), remains controversial. This study aimed to inv...
Among patients who underwent CIRT for uterine carcinoma, 101 who were followed up for > 6 months without any other therapy were retrospectively analyzed. The sacrum insufficiency fractures (SIFs) were...
At the last follow-up, 19 patients developed SIFs. Receiver operating characteristic curve analysis revealed that the sacrum D50% RBE-weighted dose was a valuable predictor of SIF. Univariate analyses...
The sacrum D50% RBE-weighted dose was identified as a risk factor for SIF. Additionally, neither LETd nor physical dose parameters were associated with SIF prediction....
The increasing number of studies dealing with linear energy transfer (LET)-based evaluation and optimization in the field of carbon ion radiotherapy (CIRT) indicates the rising demand for LET implemen...
This in silico study was conducted to benchmark the following two LET-related functionalities in a commercial TPS against Monte Carlo simulations: (1) dose averaged LET (LET...
The LET...
For all setups (homogeneous and heterogeneous), the mean absolute (and relative) LET...
No computation error was found in the tested functionalities except for LET...
A fixed relative biological effectiveness (RBE) of 1.1 (RBE...
36 patients treated with passive scattering proton therapy were selected for a case-control study from a cohort of 954 pediatric brain tumor patients. Nine children with symptomatic brainstem toxicity...
LET...
Trends towards higher LET...